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Abstract 
There are very few cases of clear cell renal
cell carcinoma with metastases to the vagina
and brain reported in the literature. Our case
study highlights this rare clinical occurrence
and its associated complications including pul-
monary embolism. In addition we discuss cur-
rent management guidelines for treating and
diagnosing the disease, and how this manage-
ment improves prognosis.
Case Report
Presentation and history
A 55-year-old African American female with
a past medical history of hypertension, nico-
tine  dependence  (stopped  smoking  eleven
years ago), and Para 2022 (status post-right
salpingectomy for ectopic pregnancy) present-
ed  with  six  weeks  of  persistent  postmeno  -
pausal bleeding per vagina (PV). Prior to pres-
entation the patient had been menopausal for
ten years and used only amlodipine and avalide
tablets as medications. She has a positive fam-
ily history (sister) of breast cancer and denied
intra-partum  exposure  to  diethyl  stilbesterol
(DES). The physical examination revealed a
loose necrotic mass with a pedunculated polyp
attached to the posterior wall of the vagina and
measuring  3.5x1.5x1  cm.  Endocervical  and
endometrial curetting were negative for malig-
nancy while polypectomy of the vaginal mass
revealed foci of necrosis, surface ulceration,
and a polypoid tumor consistent with clear cell
carcinoma of the vagina (Figure 1).
Initial management
A  computerized  tomography  (CT)  scan  of
the abdomen with contrast had been done four
months previously and showed a 4.4 cm left
kidney mass with peripheral enhancement. A
CT scan of the chest, abdomen, and pelvis done
after  the  diagnosis  of  clear  cell  malignancy
revealed a pulmonary embolism (PE) in the
left lower lobe pulmonary arteries, an enlarged
area of enhancement measuring 7 cm in the
inferior aspect of the left kidney (Figure 2),
and a 6x5.6 cm focus of soft tissue enhance-
ment in the region of the vagina (Figure 3).
These findings were suggestive of cystic renal
cell carcinoma and metastatic clear cell carci-
noma of the vagina, respectively.
Treatment
The patient was started on Lovenox (enoxa-
parin) and coumadin, but she started bleeding
PV a week later and was admitted to our inpa-
tient service with shortness of breath, and for
anticoagulation  treatment  and  inferior  vena
cava filter placement. She later underwent a
laparoscopic  hand-assisted  left  nephrectomy
with  histopathological  examination  of  the
6.6x6x4.5 cm left lower kidney pole specimen,
which was consistent with renal clear cell car-
cinoma (Figure 4). The tumor extended into
the  left  perirenal  adipose  tissue,  was  a
Fuhrman nuclear grade G3 tumor, involved the
left renal vein, and was staged as T3bN0Mx
secondary to the vaginal metastases.
Clinical course and outcome
The patient tolerated surgery well, and after
discharge received palliative radiation therapy
(4860 cGy in 27 fractions of 180 cGy) to the
pelvis.  However,  she  was  re-admitted  three
months  after  discharge  for  persistent  head  -
aches and right-sided upper extremity numb-
ness and weakness, which on CT of the head
was found to be because of a secondary left pos-
terior  parietal  mass.  She  underwent  an
intracranial incision biopsy of the left parietal
brain tumor that showed metastatic clear cell
carcinoma  histologically,  consistent  with  a
renal primary tumor. She received postopera-
tive therapeutic irradiation of the cranium for
metastatic brain lesions and recently was start-
ed on chemotherapy (Sutent 50 mg once daily
orally). She continues taking her antihyperten-
sive  medication  but  had  to  discontinue  her
anticoagulation drugs because of recurrent PV
bleeding. She currently has good performance
status and otherwise is stable medically.
Discussion
Epidemiology
Clear cell renal cell carcinoma (RCC) is the
most  common  primary  site  for  clear  cell
tumors, yet clear cell RCC metastases to the
vagina or brain are rare with only one case of
the former reported in the literature to date.
1
Eighty cases of RCC with vaginal metastases
have  been  reported  in  the  literature,
2 and
because clear cell carcinomas constitute about
80% of all renal cell carcinomas,
2 most of these
cases may be clear cell carcinomas in fact, but
are  under-reported  as  such.  Clear  cell  RCC
usually occurs in the sixth or seventh decade
of life and is three times more common in men
than in women.
2
Clinical presentation
The most common symptom on presentation
in RCC cases with vaginal metastases is vagi-
nal bleeding,
1,2 and its most common sites for
metastases  include  extra-renal  regions  like
lung, lymph nodes, liver, and bones.
1 Our case
was  unique  for  its  metastatic  sites,  clinical
presentation,  and  associated  complications.
Clear cell RCC with metastases to the vagina
and brain is very uncommon with one case of
the former
1 and none of the latter reported in
the literature. In postmenopausal women only
one case of primary clear cell carcinoma of the
vagina  has  been  reported
3 because  these
tumors tend to occur more in young patients
exposed to DES in utero.
4 Therefore, a solitary
lesion of clear cell carcinoma in the vagina in
a postmenopausal patient is more likely to be a
metastatic  secondary  than  a  primary  lesion,
and a consideration of clear cell tumor primary
sites should be performed immediately. This
was done in our case and revealed a primary
site in the left kidney, which is typically the pri-
mary site for clear cell RCC as the retrograde
filling of the left renal vein from the left ovari-
an  vein  and  uterovaginal  plexus  eventually
involves the left kidney.
5
Complications
The  vascular  effects  of  clear  cell  RCC
include the intravascular growth of the tumor
into the left renal vein, and may have caused
the tumor emboli to the left lower lung pul-
monary arteries that resulted in our patient’s
pulmonary emboli. The vascular involvements
of clear cell carcinoma are well documented in
the literature
6but this is the first reported case
with an associated pulmonary embolism.
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Diagnostic methods
Fine needle aspiration cytology to establish
the anatomic site of origin in metastatic clear
cell RCC cases, when combined with clinical
features,
7 is  95%  accurate  and  is  easier  to
administer in outpatient settings and follow-
up  cases  than  are  endometrial  biopsies.
However, the use of magnetic resonance imag-
ing (MRI) and CT scans still provide the main-
stay of primary clear cell RCC diagnoses (and
subsequent  diagnoses  of  secondary  metas-
tases) owing to their greater utility and accu-
racy.
Treatment
The use of whole body radiation therapy in
cases involving a solitary metastatic site clear
cell carcinoma currently is not recommended
as adjuvant loco-regional radiation therapy is
the preferred treatment for clear cell RCC.
8 In
diffuse  or  non-resectable  disease,  or  when
paraneoplastic syndrome, severe hemorrhage,
or severe pain is present, however, the use of
palliative nephrectomy is recommended.
9
Prognosis
Multiple metastases, recurrent metastases,
and renal vein involvements are poor prognos-
tic indicators for survival
10 and, as seen in our
patient,  are  prone  to  develop  complications
like pulmonary embolism. Patients with multi-
focal clear cell RCC (like our patient with two
metastatic sites) are more likely to have a con-
tralateral  recurrence  than  are  patients  with
solitary  clear  cell  RCC  (risk  ratio:  2.91,
p=0.142).
11
Conclusions
The development of recurrent shortness of
breadth in a clear cell RCC patient with vaginal
metastases  is  indicative  of  pulmonary
embolism,  and  the  presence  of  neurological
deficits is suggestive of brain metastases. A
high indicative index for a clear cell primary
tumor is a requirement for the diagnosis of a
secondary clear cell vaginal malignancy and for
avoiding  complications  like  pulmonary
embolism, further metastatic spread, and the
consequent deterioration of the patient.
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Case Report
Figure 1. Vaginal metastases from renal cell
carcinoma,  clear  cell  type.  Microscopic
examination of the tumor from the vagina
reveals the compact alveolar architecture of
cells with clear cytoplasm and distinct cell
boundaries  in  a  background  of  delicate
vasculature.  (H&E  stain;  magnification
100X.)
Figure 2. Computerized tomography scan
of the abdomen showing a 7 cm area of
enhancement in the left lower pole of the
kidney (arrow) consistent with renal clear
cell carcinoma.
Figure 3. Computerized tomography scan of
the pelvis showing soft tissue enhancement
measuring 6x5.6 cm in the left wall of the
vagina  (arrow)  consistent  with  metastatic
clear cell carcinoma of the vagina. 
Figure 4. Renal cell carcinoma, clear cell
type. Microscopic examination of the kid-
ney tumor shows alveolar architecture of
the cells with clear cytoplasm and distinct
cell boundaries in a background of delicate
vasculature.  (H&E  stain;  magnification
400X.)